Concepedia

Publication | Open Access

Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata

49

Citations

31

References

2022

Year

Abstract

Scalp biomarkers provide evidence of dupilumab efficacy in AA, detected even prior to clinical response, with exclusive correlations between early suppression of Th2 markers and increased hair keratins. These findings strengthen previous reports suggesting a possible role for Th2 cytokines as AA drivers.

References

YearCitations

2012

53.2K

2013

27.4K

2016

9.5K

2014

6.4K

2014

916

2018

647

2011

452

2014

284

2015

246

2009

214

Page 1